Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 30,856 shares at $99.04 ($3.1M) on 2018-03-05, disclosed to the SEC on 2018-03-06.
Open-market sale of $3.1M MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.04 | 15,428 | $1.5M | 50.0% |
| 2 | $99.04 | 15,428 | $1.5M | 50.0% |
| Total | $99.04 avg | 30,856 | $3.1M | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |